465 related articles for article (PubMed ID: 30170180)
1. Antibody-mediated rejection in the Banff classifications of 2007 and 2017: A comparison of renal graft loss prediction capability.
Solar-Cafaggi D; Marino L; Uribe-Uribe N; Morales-Buenrostro LE
Transpl Immunol; 2018 Dec; 51():40-44. PubMed ID: 30170180
[TBL] [Abstract][Full Text] [Related]
2. Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection.
Tsuji T; Yanai M; Itami H; Ishii Y; Akimoto M; Fukuzawa N; Harada H; Fukasawa Y
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():26-30. PubMed ID: 26031582
[TBL] [Abstract][Full Text] [Related]
3. Impact of the Banff 2013 classification on the diagnosis of suspicious versus conclusive late antibody-mediated rejection in allografts without acute dysfunction.
Gimeno J; Redondo D; Pérez-Sáez MJ; Naranjo-Hans D; Pascual J; Crespo M
Nephrol Dial Transplant; 2016 Nov; 31(11):1938-1946. PubMed ID: 27312147
[TBL] [Abstract][Full Text] [Related]
4. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
[TBL] [Abstract][Full Text] [Related]
5. Evolving criteria for the diagnosis of antibody-mediated rejection in renal allografts.
Haas M
Curr Opin Nephrol Hypertens; 2018 May; 27(3):137-143. PubMed ID: 29300203
[TBL] [Abstract][Full Text] [Related]
6. An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts.
Haas M
Curr Opin Organ Transplant; 2014 Jun; 19(3):315-22. PubMed ID: 24811440
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib for refractory acute antibody-mediated rejection in kidney transplant recipients: A single-centre case series.
De Sousa-Amorim E; Revuelta I; Diekmann F; Cofan F; Lozano M; Cid J; Palou E; Sole M; Campistol JM; Oppenheimer F
Nephrology (Carlton); 2016 Aug; 21(8):700-4. PubMed ID: 26492594
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
9. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
Vo AA; Sinha A; Haas M; Choi J; Mirocha J; Kahwaji J; Peng A; Villicana R; Jordan SC
Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792
[TBL] [Abstract][Full Text] [Related]
10. Banff 2013 update: Pearls and pitfalls in transplant renal pathology.
Hara S
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():2-8. PubMed ID: 26031578
[TBL] [Abstract][Full Text] [Related]
11. The Revised (2013) Banff Classification for Antibody-Mediated Rejection of Renal Allografts: Update, Difficulties, and Future Considerations.
Haas M
Am J Transplant; 2016 May; 16(5):1352-7. PubMed ID: 26696524
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation.
Callemeyn J; Ameye H; Lerut E; Senev A; Coemans M; Van Loon E; Sprangers B; Van Sandt V; Rabeyrin M; Dubois V; Thaunat O; Kuypers D; Emonds MP; Naesens M
Am J Transplant; 2021 Jul; 21(7):2413-2423. PubMed ID: 33382185
[TBL] [Abstract][Full Text] [Related]
13. Current pathological perspectives on chronic rejection in renal allografts.
Hara S
Clin Exp Nephrol; 2017 Dec; 21(6):943-951. PubMed ID: 27848058
[TBL] [Abstract][Full Text] [Related]
14. Role of time from transplantation to biopsy in histologic ABMR: A single center report.
Chancay J; Liu C; Chauhan K; Andersen L; Harris C; Coca S; Delaney V; Tedla F; De Boccardo G; Sehgal V; Moledina D; Formica R; Reghuvaran A; Banu K; Florman S; Akalin E; Shapiro R; Salem F; Menon MC
Clin Transplant; 2022 Dec; 36(12):e14802. PubMed ID: 36069577
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Revised Banff Criteria in the Diagnosis of Antibody-Mediated Rejection.
Jeong HS; Kim DG; Lee ST; Huh KH; Kim YS; Jeong HJ; Lim BJ
Transplant Proc; 2019 Jun; 51(5):1488-1490. PubMed ID: 31053345
[TBL] [Abstract][Full Text] [Related]
16. Significance of C4d deposition in antibody-mediated rejection.
Takeda A; Otsuka Y; Horike K; Inaguma D; Hiramitsu T; Yamamoto T; Nanmoku K; Goto N; Watarai Y; Uchida K; Morozumi K; Kobayashi T
Clin Transplant; 2012 Jul; 26 Suppl 24():43-8. PubMed ID: 22747475
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of paediatric kidney transplant recipients using the updated 2013/2017 Banff histopathological classification for antibody-mediated rejection.
Preka E; Sekar T; Lopez Garcia SC; Shaw O; Kessaris N; Mamode N; Stojanovic J; Sebire NJ; Kim JJ; Marks SD
Pediatr Nephrol; 2021 Aug; 36(8):2575-2585. PubMed ID: 34143297
[TBL] [Abstract][Full Text] [Related]
18. A 2020 Banff Antibody-mediatedInjury Working Group examination of international practices for diagnosing antibody-mediated rejection in kidney transplantation - a cohort study.
Schinstock CA; Askar M; Bagnasco SM; Batal I; Bow L; Budde K; Campbell P; Carroll R; Clahsen-van Groningen MC; Cooper M; Cornell LD; Cozzi E; Dadhania D; Diekmann F; Hesselink DA; Jackson AM; Kikic Z; Lower F; Naesens M; Roelofs JJ; Sapir-Pichhadze R; Kraus ES
Transpl Int; 2021 Mar; 34(3):488-498. PubMed ID: 33423340
[TBL] [Abstract][Full Text] [Related]
19. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.
Sis B; Halloran PF
Curr Opin Organ Transplant; 2010 Feb; 15(1):42-8. PubMed ID: 20009933
[TBL] [Abstract][Full Text] [Related]
20. A case of chronic antibody-mediated rejection in the making.
Bravou V; Galliford J; McLean A; Willicombe M; Taube D; Cook HT; Roufosse C
Clin Nephrol; 2013 Oct; 80(4):306-9. PubMed ID: 22579273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
